Insider Transactions Reported by 12 Insiders of BioAge Labs, Inc.

Symbol
BIOA on Nasdaq
Location
Emeryville, CA

Insiders trading volume in the past year

BioAge Labs, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Vijay Satyanand Pande Director $58,197,060 07 Aug 2025
James Healy Director $41,488,218 05 Jun 2025
Patrick G. Enright Director $30,790,602 05 Jun 2025
Cormorant Asset Management, LP Former 10% Owner $29,331,522 27 Sep 2024
Kristen Fortney Chief Executive Officer, Director $17,698,701 -$4,223,036 -19% 17 Feb 2026
Dov A. Goldstein MD Chief Financial Officer $144,684 -$531,828 -79% 01 Mar 2026
Rekha Hemrajani Director $54,000 05 Jun 2025
Shane Barton Principal Accounting Officer $47,376 17 Feb 2026
Paul D. Rubin Chief Medical Officer $0 -$1,303,658 -100% 02 Mar 2026
Michael H. Davidson Director 05 Jun 2025
Jean Pierre Garnier Director 05 Jun 2025
Eric Morgen Chief Operating Officer, Director 17 Feb 2026

Recent Insider Transactions by Companies or Individuals for BioAge Labs, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Paul D. Rubin BIOA Common Stock Sale -100% $150,890 $20.30 -7,433 0 02 Mar 2026 Direct
Paul D. Rubin BIOA Common Stock Options Exercise 7,433 7,433 02 Mar 2026 Direct
Paul D. Rubin BIOA Stock Option (Right to Buy) Options Exercise -68.7% -7,433 3,383 02 Mar 2026 Direct
Dov A. Goldstein MD BIOA Common Stock Options Exercise 12% 3,542 33,033 01 Mar 2026 Direct
Dov A. Goldstein MD BIOA Stock Option (Right to Buy) Options Exercise -2.17% -3,542 159,375 01 Mar 2026 Direct
Paul D. Rubin BIOA Stock Option (Right to Buy) Award 110,000 110,000 17 Feb 2026 Direct
Eric Morgen BIOA Stock Option (Right to Buy) Award 12,500 12,500 17 Feb 2026 By Spouse
Eric Morgen BIOA Stock Option (Right to Buy) Award 110,000 110,000 17 Feb 2026 Direct
Dov A. Goldstein MD BIOA Stock Option (Right to Buy) Award 110,000 110,000 17 Feb 2026 Direct
Kristen Fortney BIOA Stock Option (Right to Buy) Award 330,000 330,000 17 Feb 2026 Direct
Shane Barton BIOA Stock Option (Right to Buy) Award 45,000 45,000 17 Feb 2026 Direct
Paul D. Rubin BIOA Common Stock Sale -100% $139,369 $18.75 -7,433 0 02 Feb 2026 Direct
Paul D. Rubin BIOA Common Stock Options Exercise 7,433 7,433 02 Feb 2026 Direct
Paul D. Rubin BIOA Stock Option (Right to Buy) Options Exercise -58% -7,433 5,383 02 Feb 2026 Direct
Dov A. Goldstein MD BIOA Common Stock Options Exercise 13.6% 3,541 29,491 01 Feb 2026 Direct
Dov A. Goldstein MD BIOA Stock Option (Right to Buy) Options Exercise -2.13% -3,541 162,917 01 Feb 2026 Direct
Dov A. Goldstein MD BIOA Common Stock Options Exercise 15.8% 3,542 25,950 16 Jan 2026 Direct
Dov A. Goldstein MD BIOA Stock Option (Right to Buy) Options Exercise -2.08% -3,542 166,458 16 Jan 2026 Direct
Dov A. Goldstein MD BIOA Common Stock Sale -54.6% $531,828 $19.70 -27,000 22,408 13 Jan 2026 Direct
Dov A. Goldstein MD BIOA Common Stock Options Exercise 120.5% 27,000 49,408 13 Jan 2026 Direct
Dov A. Goldstein MD BIOA Stock Option (Right to Buy) Options Exercise -22.6% -27,000 92,587 13 Jan 2026 Direct
Kristen Fortney BIOA Common Stock Sale -19.3% $4,223,036 $18.12 -233,107 976,949 13 Jan 2026 Direct
Paul D. Rubin BIOA Common Stock Sale -100% $95,490 $12.85 -7,433 0 02 Jan 2026 Direct
Paul D. Rubin BIOA Common Stock Options Exercise 7,433 7,433 02 Jan 2026 Direct
Paul D. Rubin BIOA Stock Option (Right to Buy) Options Exercise -50.2% -7,433 7,383 02 Jan 2026 Direct
Paul D. Rubin BIOA Common Stock Sale -100% $216,000 $12.00 -18,000 0 09 Dec 2025 Direct
Paul D. Rubin BIOA Common Stock Options Exercise 18,000 18,000 09 Dec 2025 Direct
Paul D. Rubin BIOA Stock Option (Right to Buy) Options Exercise -65.7% -18,000 9,383 09 Dec 2025 Direct
Paul D. Rubin BIOA Common Stock Sale -100% $701,909 $10.19 -68,897 0 04 Dec 2025 Direct
Paul D. Rubin BIOA Common Stock Options Exercise 68,897 68,897 04 Dec 2025 Direct
Paul D. Rubin BIOA Stock Option (Right to Buy) Options Exercise -76% -68,897 21,736 04 Dec 2025 Direct
Vijay Satyanand Pande BIOA Stock Option (Right to Buy) Award 22,000 22,000 07 Aug 2025 Direct
Rekha Hemrajani BIOA Stock Option (Right to Buy) Award 22,000 22,000 05 Jun 2025 Direct
James Healy BIOA Stock Option (Right to Buy) Award 22,000 22,000 05 Jun 2025 Direct
Patrick G. Enright BIOA Stock Option (Right to Buy) Award 22,000 22,000 05 Jun 2025 Direct
Michael H. Davidson BIOA Stock Option (Right to Buy) Award 22,000 22,000 05 Jun 2025 Direct
Jean Pierre Garnier BIOA Stock Option (Right to Buy) Award 22,000 22,000 05 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.